Gossamer Bio, Inc.
GOSS • NASDAQ
Gossamer Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Faheem Hasnain, with a market cap of $87.2M.
Market Cap$87.2M
Employees135.0
CEOFaheem Hasnain
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Gossamer Bio, Inc. FAQ
Common questions about Gossamer Bio, Inc.
Gossamer Bio, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $5.0M.
Gossamer Bio, Inc. has approximately 135 employees.